Viewing Study NCT05605535


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2025-12-28 @ 1:09 AM
Study NCT ID: NCT05605535
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-11
First Post: 2022-10-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer
Sponsor: CanariaBio Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module